BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17896315)

  • 1. Retinal dysfunction in carriers of bardet-biedl syndrome.
    Kim LS; Fishman GA; Seiple WH; Szlyk JP; Stone EM
    Ophthalmic Genet; 2007 Sep; 28(3):163-8. PubMed ID: 17896315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal ERG findings in carriers of X-linked retinoschisis.
    Kim LS; Seiple W; Fishman GA; Szlyk JP
    Doc Ophthalmol; 2007 Jan; 114(1):21-6. PubMed ID: 17180613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mosaic retinal dysfunction in choroideremia carriers electroretinographic and psychophysical testing.
    Vajaranant TS; Fishman GA; Szlyk JP; Grant-Jordan P; Lindeman M; Seiple W
    Ophthalmology; 2008 Apr; 115(4):723-9. PubMed ID: 18201765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection using the multifocal electroretinogram of mosaic retinal dysfunction in carriers of X-linked retinitis pigmentosa.
    Vajaranant TS; Seiple W; Szlyk JP; Fishman GA
    Ophthalmology; 2002 Mar; 109(3):560-8. PubMed ID: 11874762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal disease expression in Bardet-Biedl syndrome-1 (BBS1) is a spectrum from maculopathy to retina-wide degeneration.
    Azari AA; Aleman TS; Cideciyan AV; Schwartz SB; Windsor EA; Sumaroka A; Cheung AY; Steinberg JD; Roman AJ; Stone EM; Sheffield VC; Jacobson SG
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5004-10. PubMed ID: 17065520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundus autofluorescence in carriers of choroideremia and correlation with electrophysiologic and psychophysical data.
    Preising MN; Wegscheider E; Friedburg C; Poloschek CM; Wabbels BK; Lorenz B
    Ophthalmology; 2009 Jun; 116(6):1201-9.e1-2. PubMed ID: 19376587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal function in carriers of Bardet-Biedl syndrome.
    Cox GF; Hansen RM; Quinn N; Fulton AB
    Arch Ophthalmol; 2003 Jun; 121(6):804-10. PubMed ID: 12796250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifocal electroretinogram in occult macular dystrophy.
    Piao CH; Kondo M; Tanikawa A; Terasaki H; Miyake Y
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):513-7. PubMed ID: 10670483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of retinal abnormalities on the multifocal visual evoked potential.
    Chen JY; Hood DC; Odel JG; Behrens MM
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4378-85. PubMed ID: 17003429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
    Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
    Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy.
    Fortune B; Schneck ME; Adams AJ
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2638-51. PubMed ID: 10509661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of central retinal function in patients with advanced retinitis pigmentosa.
    Gerth C; Wright T; Héon E; Westall CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1312-8. PubMed ID: 17325178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocal electroretinogram contributes to differentiation of various clinical pictures within a family with Bardet-Biedl syndrome.
    Praidou A; Hagan R; Nayak H; Chandna A
    Eye (Lond); 2014 Sep; 28(9):1136-42. PubMed ID: 24993321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Functional visual explorations of Bardet-Biedl syndrome. A study of three cases].
    Ingster-Moati I; Rigaudiere F; Choltus-De Petigny MC; Bremond-Gignac D; Lestrade C; Grall Y
    J Fr Ophtalmol; 2000 Oct; 23(8):802-8. PubMed ID: 11033503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spatial resolution of the porcine multifocal electroretinogram for detection of laser-induced retinal lesions.
    Kyhn MV; Kiilgaard JF; Scherfig E; Prause JU; la Cour M
    Acta Ophthalmol; 2008 Nov; 86(7):786-93. PubMed ID: 18754822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype correlations in Bardet-Biedl syndrome.
    Daniels AB; Sandberg MA; Chen J; Weigel-DiFranco C; Fielding Hejtmancic J; Berson EL
    Arch Ophthalmol; 2012 Jul; 130(7):901-7. PubMed ID: 22410627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominantly Cone-System Dysfunction as Rare Form of Retinal Degeneration in Patients With Molecularly Confirmed Bardet-Biedl Syndrome.
    Scheidecker S; Hull S; Perdomo Y; Studer F; Pelletier V; Muller J; Stoetzel C; Schaefer E; Defoort-Dhellemmes S; Drumare I; Holder GE; Hamel CP; Webster AR; Moore AT; Puech B; Dollfus HJ
    Am J Ophthalmol; 2015 Aug; 160(2):364-372.e1. PubMed ID: 25982971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
    Lyons JS; Severns ML
    Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local diabetic retinopathy prediction by multifocal ERG delays over 3 years.
    Ng JS; Bearse MA; Schneck ME; Barez S; Adams AJ
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1622-8. PubMed ID: 18385083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy.
    Lai TY; Chan WM; Li H; Lai RY; Lam DS
    Am J Ophthalmol; 2005 Nov; 140(5):794-807. PubMed ID: 16310457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.